[Antiviral agents and the practicing physician].
Vesikari
T
T
Tampereen yliopiston lääketieteen laitos 33014 Tampereen yliopisto. timo.vesikari@uta.fi
Paavonen
J
J
D015075:2-Aminopurine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000212:Acyclovir / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D000077595:Famciclovir; D005194:Family Practice / Q000639:trends*; D005260:Female; D006566:Herpesviridae Infections / Q000188:drug therapy / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D008297:Male; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D015229:Sexually Transmitted Diseases, Viral / Q000188:drug therapy / Q000517:prevention & control; D014777:Virus Diseases / Q000188:drug therapy* / Q000517:prevention & control
D000998:Antiviral Agents; D015075:2-Aminopurine; D000077595:Famciclovir; D000212:Acyclovir
Viruslääkkeet ja käytännön lääkäri.